A Venture Capitalist's Advice to Aspiring Blockchain Entrepreneurs
Blockchain is one of the hottest topics in the business world right now. But venture capitalist Carter Reum, author of “Shortcut Your Startup”, warns against turning to crypto in an attempt to make easy money.
“Anyone smart knows that the blockchain is here to stay, and can be very disruptive,” he said. “[But] I think too many people think, ‘I’m going to buy it for X and sell it for X, and I’ll be rich.’ Or ‘I’m going to buy a mining machine.’”
“My Lyft driver told me the other day that he bought a mining machine. That’s pretty scary.”
Reum, co-founder of investment firm M13, has invested in over 130 companies such as SpaceX, Pinterest, and Slack.
He says that entrepreneurs looking for affordable or new investments should consider looking into companies “coming out of the gate.”
“What’s exciting is that you’re about to have a lot of great tech IPOs, I think over the next 18 to 24 months,” he said. “So consumers will get exposure to companies like Pinterest, like Lyft, which they previously didn’t have exposure to.”
For full interview [click here](https://cheddar.com/videos/unconventional-advice-for-aspiring-entrepreneurs).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
